CAJ | 학술논문

目的：：观察鼻内窥镜下行泪囊鼻腔吻合术后,置入一种新型多功能泪道支架治疗鼻泪道阻塞的近期及中期疗效,并评价其临床应用价值。方法：回顾性系列病例研究。对76例79眼鼻泪道阻塞患者行泪囊鼻腔吻合术后,置入多功能泪道支架,术后2~3 mo拔管,拔管后随访3~6 mo。结果：患者79眼中,成功植入支架77眼,手术成功率为97.5%；术后2~3 mo全部成功拔管,拔管后随访3~6 mo；不溢泪、泪道冲洗畅通60眼；溢泪症状改善、泪道冲洗部分返流15眼,总有效率为97.4%,2眼未愈；术后未发生支架移位脱落等并发症,吻合口均上皮化良好。结论：该多功能泪道支架具有手术方法简单快捷、并发症少、恢复快等优点,能大大提高鼻内镜下泪囊鼻腔吻合术的成功率和适用范围,是一种安全、有效治疗鼻泪道阻塞的新方法。
목적：：관찰비내규경하행루낭비강문합술후,치입일충신형다공능루도지가치료비루도조새적근기급중기료효,병평개기림상응용개치。방법：회고성계렬병례연구。대76례79안비루도조새환자행루낭비강문합술후,치입다공능루도지가,술후2~3 mo발관,발관후수방3~6 mo。결과：환자79안중,성공식입지가77안,수술성공솔위97.5%；술후2~3 mo전부성공발관,발관후수방3~6 mo；불일루、루도충세창통60안；일루증상개선、루도충세부분반류15안,총유효솔위97.4%,2안미유；술후미발생지가이위탈락등병발증,문합구균상피화량호。결론：해다공능루도지가구유수술방법간단쾌첩、병발증소、회복쾌등우점,능대대제고비내경하루낭비강문합술적성공솔화괄용범위,시일충안전、유효치료비루도조새적신방법。
To observe the reliability and short-term and mid-term efficacy of a new designed multi-functional lacrimal sac nasal drainage stent on the treatment of nasolacrimal duct obstruction after endonasal endoscopic dacryocystorhinostomy ( EES-DCR ) , and to evaluate its clinical application value. METHODS: A retrospective case series study was carried out. Seventy - six patients ( 79 eyes ) with nasolacrimal duct obstruction underwent EES-DCR and a new type of multi-functional lacrimal sac nasal drainage stent was implanted. The nasal lacrimal drainage stent was pulled out 2~3mo later after surgery and the patients received 3~6mo follow-up afterwards. RESULTS: ln 79 eyes, stents were successfully implanted in 77 eyes (97. 5%). All stents of 77 eyes could be pulled out successfully 2 ~ 3mo after the operation. Sixty eyes were cured with unobstructed lacrimal irrigation and symptom of epiphora disappeared;15 eyes were improved of epiphora and mild reflux during lacrimal irrigation were found, overall effective rate was 97. 4%, 2 eyes failed in stent implantation. ln 6mo follow-up, nocomplications such as stent displacement or slip was occurred, the epithelization of anastomotic stoma was good.CONCLUSlON: Surgical technique of using the multi-function nasolacrimal stent is simple and fast, and implantation of the new designed stents has a rapid recovery with fewer complications. The usage of the new stents not only improves the success rate but also broadens surgical indications of EES-DCR, it is a safe and effective method for the treatment of nasolacrimal duct obstruction.